COVID roadblocks persist, but the path may be clearing for Soft Tissue Fixation
While COVID was still causing roadblocks for the overall medical device market, Soft Tissue Fixation was able to see some light at the end of the tunnel as case volumes for Orthopedic Sports Medicine procedures started to climb back towards pre-COVID levels.
Q1 Soft Tissue Fixation saw positive revenue growth across all segments over the previous year, especially towards the end of the quarter where case volumes started to pick back up compared to the same period last year, when case volumes plummeted due to the start of the COVID pandemic.
Among the many topics covered in the comprehensive Q121 Soft Tissue Fixation Market Recap* are:
- Complete STF Market Overview
- Top Competitor Results, incl Arthrex, Smith & Nephew, JNJ Depuy Synthes
- Q121 Clinical & Regulatory Highlights
- Q121 Events and Highlights
According to SmartTRAK Financial Dashboard, Worldwide in Q1, the Soft Tissue Fixation market was up 8.5% YoY, with revenues of 
* in Q121. At the regional level, US Soft Tissue Fixation ended Q1 with positive gains over the previous year with revenues of ...
SmartTRAK is a comprehensive, easy-to-use, business intelligence solution that networks an entire organization with real-time market data and analysis. Used by the 15 top Advanced Wound Care companies and 8 of the 10 top Orthopedic companies, SmartTRAK transforms the delivery of healthcare business information into a cost-effective solution for life science corporations to increase proficiency, improve productivity and reduce cost.
